Apollo Care
Apollo Care is a 503B outsourcing facility based in Columbia, MO. A government record names semaglutide and tirzepatide at Apollo Care; the newest is an FDA recall dated July 29, 2026. It fills prescriptions; it doesn’t write them, so you can’t get a GLP-1 from Apollo Care without a prescription from a licensed clinician.1
How to get a GLP‑1 filled by Apollo CareChecked November 20, 2026 against FDA, CMS and state board records. Every fact links to its source.
Apollo Care at a glance
How to get a GLP‑1 filled by Apollo Care
To get a GLP‑1 from Apollo Care, you first need a prescription: it fills prescriptions; it doesn’t write them or sell without one. An online program takes you through the steps: you fill in a health questionnaire, a licensed clinician reviews it, and if they prescribe, the program’s pharmacy ships the medication to you.
These are the three programs ranked highest on our score. Check that a program ships to your state before you sign up.
- 1Health questionnaire, online
- 2A licensed clinician decides
- 3The pharmacy ships to you
We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money
Prefer your own clinician? You’re free to: ask them to send your prescription to Apollo Care or another licensed pharmacy.
See every program we rankWhat ties Apollo Care to GLP‑1s
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0755-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material3
“SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0747-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material4
“SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0748-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material5
“SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0753-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material6
“SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0749-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material7
“SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0752-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material8
“SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0757-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material9
“SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0756-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material10
“SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0751-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material11
“SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0750-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material12
“SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03”
- FDA recallJuly 29, 2026 · semaglutideClass II recall D-0754-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material13
“SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03”
- FDA inspection report (Form 483)July 28, 2026 · semaglutide and tirzepatideFDA Form 483 inspectional observations, Apollo Care LLC, issued 2026-07-2814
“reviewed retain samples of Semaglutide Injection and Semaglutide with Glycine Injection drug product vials”
Apollo Care’s FDA record
| Date | What the FDA did |
|---|---|
| July 28, 2026 | 483 Issued 07/28/202614 |
| February 2, 2026 | Warning Letter (02/02/2026)15 |
| March 27, 2025 | 483 Issued 03/27/202516 |
| November 27, 2023 | Regulatory Meeting Held 11/27/2023 |
| April 5, 2023 | 483 Issued 04/05/202317 |
| September 8, 2021 | 483 Issued 09/8/202118 |
| March 20, 2019 | Warning Letter (03/20/2019)19 |
What a compounded GLP‑1 is, and what it isn’t
The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12.2324 Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.2220
Apollo Care: questions
- 1.NPI Registry: APOLLO CARE, LLC (NPI 1124566989)Centers for Medicare & Medicaid Servicesretrieved 2026-11-20↩
- 2.Registered Outsourcing FacilitiesU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 3.Class II recall D-0755-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01”
- 4.Class II recall D-0747-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05”
- 5.Class II recall D-0748-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02”
- 6.Class II recall D-0753-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02”
- 7.Class II recall D-0749-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01”
- 8.Class II recall D-0752-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01”
- 9.Class II recall D-0757-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.”
- 10.Class II recall D-0756-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02”
- 11.Class II recall D-0751-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02”
- 12.Class II recall D-0750-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03”
- 13.Class II recall D-0754-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03”
- 14.FDA Form 483 inspectional observations, Apollo Care LLC, issued 2026-07-28FDAretrieved 2026-07-28↩“reviewed retain samples of Semaglutide Injection and Semaglutide with Glycine Injection drug product vials”
- 15.FDA: Warning Letter (02/02/2026)U.S. Food and Drug Administration↩
- 16.FDA: 483 Issued 03/27/2025 (PDF - 2 MB)U.S. Food and Drug Administration↩
- 17.FDA: 483 Issued 04/05/2023 (PDF - 2 MB)U.S. Food and Drug Administration↩
- 18.FDA: 483 Issued 09/8/2021 (PDF - 2 MB)U.S. Food and Drug Administration↩
- 19.FDA: Warning Letter (03/20/2019)U.S. Food and Drug Administration↩
- 20.Compounding inspections, recalls, and other actionsU.S. Food and Drug Administrationretrieved 2026-11-20↩
- 21.Missouri license lookupmopro.mo.gov↩
- 22.Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration↩
- 23.
- 24.
A pharmacy’s record can change after the day we read it: check its license with its state board before you fill a prescription. An FDA document is an allegation or an observation the FDA has published, not a court finding. This page is educational and is not medical advice.